Changes in S100 calcium-binding protein β (S100β) and cognitive function from pre- to post-chemotherapy among women with breast cancer
Authors:
Open Access
- 8 September 2024
- journal article
- research article
- Published by Elsevier in Brain, Behavior, & Immunity - Health
- Vol. 41, 100860
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Relationships between cytokines and cognitive function from pre- to post-chemotherapy in patients with breast cancerJournal of Neuroimmunology, 2022
- Self‐reported cognitive impairment in cervical cancer survivors: A cross‐sectional studyPsycho-Oncology, 2021
- Serum S100B represents a biomarker for cognitive impairment in patients with end-stage renal diseaseClinical Neurology and Neurosurgery, 2020
- Racial Differences in S100b Levels in Persons with SchizophreniaPsychiatric Quarterly, 2019
- Over-expression of S100B protein as a serum marker of brain metastasis in non-small cell lung cancer and its prognostic valuePathology - Research and Practice, 2019
- Utility of S100B Serum Level for the Determination of Concussion in Male Rugby PlayersSports Medicine, 2016
- Clinical Use of the Calcium-Binding S100B Protein2012
- Vitamin E increases S100B‐mediated microglial activation in an S100B‐overexpressing mouse model of pathological agingGlia, 2008
- Further validation of the multidimensional fatigue symptom inventory-short formJournal of Pain and Symptom Management, 2004
- Serum S100βCancer, 2003